|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Wang KK and Sampliner RE; Practice
Parameters Committee of the American College of Gastroenterology.
Updated guidelines 2008 for the diagnosis, surveillance and therapy
of Barrett's esophagus. Am J Gastroenterol. 103:788–797. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: A new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cazzoli R, Buttitta F, Di Nicola M,
Malatesta S, Marchetti A, Rom WN and Pass HI: microRNAs derived
from circulating exosomes as noninvasive biomarkers for screening
and diagnosing lung cancer. J Thorac Oncol. 8:1156–1162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manterola L, Guruceaga E, Gállego
Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S,
Diez-Valle R, Segura V, Samprón N, Barrena C, et al: A small
noncoding RNA signature found in exosomes of GBM patient serum as a
diagnostic tool. Neuro Oncol. 16:520–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu R, Liao J, Yang M, Shi Y, Peng Y, Wang
Y, Pan E, Guo W, Pu Y and Yin L: Circulating miR-155 expression in
plasma: A potential biomarker for early diagnosis of esophageal
cancer in humans. J Toxicol Environ Health A. 75:1154–1162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ali S, Almhanna K, Chen W, Philip PA and
Sarkar FH: Differentially expressed miRNAs in the plasma may
provide a molecular signature for aggressive pancreatic cancer. Am
J Transl Res. 3:28–47. 2010.PubMed/NCBI
|
|
8
|
Wang HY, Yan LX, Shao Q, Fu S, Zhang ZC,
Ye W, Zeng YX and Shao JY: Profiling plasma microRNA in
nasopharyngeal carcinoma with deep sequencing. Clin Chem.
60:773–782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng L, Sharples RA, Scicluna BJ and Hill
AF: Exosomes provide a protective and enriched source of miRNA for
biomarker profiling compared to intracellular and cell-free blood.
J Extracell Vesicles. 3:32014.
|
|
10
|
Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z:
miRNA in plasma exosome is stable under different storage
conditions. Molecules. 19:1568–1575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Salido-Guadarrama I, Romero-Cordoba S,
Peralta-Zaragoza O, Hidalgo-Miranda A and Rodríguez-Dorantes M:
MicroRNAs transported by exosomes in body fluids as mediators of
intercellular communication in cancer. Onco Targets Ther.
7:1327–1338. 2014.PubMed/NCBI
|
|
12
|
Ramachandran S and Palanisamy V:
Horizontal transfer of RNAs: Exosomes as mediators of intercellular
communication. Wiley Interdiscip Rev RNA. 3:286–293. 2012.
View Article : Google Scholar :
|
|
13
|
Kosaka N, Yoshioka Y, Hagiwara K, Tominaga
N, Katsuda T and Ochiya T: Trash or treasure: Extracellular
microRNAs and cell-to-cell communication. Front Genet. 4:1732013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rabinowits G, Gerçel-Taylor C, Day JM,
Taylor DD and Kloecker GH: Exosomal microRNA: A diagnostic marker
for lung cancer. Clin Lung Cancer. 10:42–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tadokoro H, Umezu T, Ohyashiki K, Hirano T
and Ohyashiki JH: Exosomes derived from hypoxic leukemia cells
enhance tube formation in endothelial cells. J Biol Chem.
288:34343–34351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nouraee N, Van Roosbroeck K, Vasei M,
Semnani S, Samaei NM, Naghshvar F, Omidi AA, Calin GA and Mowla SJ:
Expression, tissue distribution and function of miR-21 in
esophageal squamous cell carcinoma. PLoS One. 8:e730092013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh R, Pochampally R, Watabe K, Lu Z and
Mo YY: Exosome-mediated transfer of miR-10b promotes cell invasion
in breast cancer. Mol Cancer. 13:2562014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Umezu T, Ohyashiki K, Kuroda M and
Ohyashiki JH: Leukemia cell to endothelial cell communication via
exosomal miRNAs. Oncogene. 32:2747–2755. 2013. View Article : Google Scholar
|
|
20
|
Liao J, Liu R, Yin L and Pu Y: Expression
profiling of exosomal miRNAs derived from human esophageal cancer
cells by Solexa high-throughput sequencing. Int J Mol Sci.
15:15530–15551. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han Y, Wei F, Xu X, Cai Y, Chen B, Wang J,
Xia S, Hu H, Huang X, Han Y, et al: Establishment and comparative
genomic hybridization analysis of human esophageal carcinomas cell
line EC9706. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 19:455–457.
2002.(In Chinese). PubMed/NCBI
|
|
22
|
Ji H, Erfani N, Tauro BJ, Kapp EA, Zhu HJ,
Moritz RL, Lim JW and Simpson RJ: Difference gel electrophoresis
analysis of Ras-transformed fibroblast cell-derived exosomes.
Electrophoresis. 29:2660–2671. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang M, Chen J, Su F, Yu B, Su F, Lin L,
Liu Y, Huang JD and Song E: Microvesicles secreted by macrophages
shuttle invasion-potentiating microRNAs into breast cancer cells.
Mol Cancer. 10:1172011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tian T, Wang Y, Wang H, Zhu Z and Xiao Z:
Visualizing of the cellular uptake and intracellular trafficking of
exosomes by live-cell microscopy. J Cell Biochem. 111:488–496.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kosaka N, Iguchi H, Yoshioka Y, Takeshita
F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular
transfer of microRNAs in living cells. J Biol Chem.
285:17442–17452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kosaka N, Iguchi H, Yoshioka Y, Hagiwara
K, Takeshita F and Ochiya T: Competitive interactions of cancer
cells and normal cells via secretory microRNAs. J Biol Chem.
287:1397–1405. 2012. View Article : Google Scholar :
|
|
27
|
Allgayer H: Pdcd4, a colon cancer
prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol.
73:185–191. 2010. View Article : Google Scholar
|
|
28
|
Li L, Zhou L, Li Y, Lin S and Tomuleasa C:
MicroRNA-21 stimulates gastric cancer growth and invasion by
inhibiting the tumor suppressor effects of programmed cell death
protein 4 and phosphatase and tensin homolog. J BUON. 19:228–236.
2014.PubMed/NCBI
|
|
29
|
Liu T, Liu Q, Zheng S, Gao X, Lu M, Yang
C, Dai F, Sheyhidin I and Lu X: MicroRNA-21 promotes cell growth
and migration by targeting programmed cell death 4 gene in Kazakh's
esophageal squamous cell carcinoma. Dis Markers. 2014:2328372014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kahlert C and Kalluri R: Exosomes in tumor
microenvironment influence cancer progression and metastasis. J Mol
Med Berl. 91:431–437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JK, Park SR, Jung BK, Jeon YK, Lee YS,
Kim MK, Kim YG, Jang JY and Kim CW: Exosomes derived from
mesenchymal stem cells suppress angiogenesis by down-regulating
VEGF expression in breast cancer cells. PLoS One. 8:e842562013.
View Article : Google Scholar
|
|
32
|
Tetta C, Ghigo E, Silengo L, Deregibus MC
and Camussi G: Extracellular vesicles as an emerging mechanism of
cell-to-cell communication. Endocrine. 44:11–19. 2013. View Article : Google Scholar :
|
|
33
|
Ismail N, Wang Y, Dakhlallah D, Moldovan
L, Agarwal K, Batte K, Shah P, Wisler J, Eubank TD, Tridandapani S,
et al: Macrophage microvesicles induce macrophage differentiation
and miR-223 transfer. Blood. 121:984–995. 2013. View Article : Google Scholar :
|
|
34
|
Shimbo K, Miyaki S, Ishitobi H, Kato Y,
Kubo T, Shimose S and Ochi M: Exosome-formed synthetic microRNA-143
is transferred to osteosarcoma cells and inhibits their migration.
Biochem Biophys Res Commun. 445:381–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao J, Zhang Q, Xu J, Guo L and Li X:
Clinical significance of serum miR-21 in breast cancer compared
with CA153 and CEA. Chin J Cancer Res. 25:743–748. 2013.
|
|
36
|
Gao W, Xu J, Liu L, Shen H, Zeng H and Shu
Y: A systematic-analysis of predicted miR-21 targets identifies a
signature for lung cancer. Biomed Pharmacother. 66:21–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Selcuklu SD, Donoghue MTA and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang N, Zhang CQ, He JH, Duan XF, Wang YY,
Ji X, Zang WQ, Li M, Ma YY, Wang T, et al: MiR-21 down-regulation
suppresses cell growth, invasion and induces cell apoptosis by
targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig
Dis Sci. 58:1863–1870. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lou Y, Cui Z, Wang F, Yang X and Qian J:
miR-21 down-regulation promotes apoptosis and inhibits invasion and
migration abilities of OVCAR3 cells. Clin Invest Med.
34:E2812011.PubMed/NCBI
|
|
40
|
Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and
Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation,
invasion, migration, and apoptosis by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One.
9:e1036982014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M,
et al: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tanaka Y, Kamohara H, Kinoshita K,
Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M and Baba H:
Clinical impact of serum exosomal microRNA-21 as a clinical
biomarker in human esophageal squamous cell carcinoma. Cancer.
119:1159–1167. 2013. View Article : Google Scholar
|
|
43
|
Kosaka N, Iguchi H, Hagiwara K, Yoshioka
Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2
(nSMase2)-dependent exosomal transfer of angiogenic microRNAs
regulate cancer cell metastasis. J Biol Chem. 288:10849–10859.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma G, Zhang H, Dong M, Zheng X, Ozaki I,
Matsuhashi S and Guo K: Downregulation of programmed cell death 4
(PDCD4) in tumorigenesis and progression of human digestive tract
cancers. Tumour Biol. 34:3879–3885. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang D, Guo S, Han SY, Xu N, Guo JY and
Sun Q: Distinct roles of different fragments of PDCD4 in regulating
the metastatic behavior of B16 melanoma cells. Int J Oncol.
42:1725–1733. 2013.PubMed/NCBI
|
|
46
|
Lankat-Buttgereit B and Göke R: The tumour
suppressor Pdcd4: Recent advances in the elucidation of function
and regulation. Biol Cell. 101:309–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang YY, Chen B and Ding YQ:
Metastasis-associated factors facilitating the progression of
colorectal cancer. Asian Pac J Cancer Prev. 13:2437–2444. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yadav L, Puri N, Rastogi V, Satpute P,
Ahmad R and Kaur G: Matrix metalloproteinases and cancer - roles in
threat and therapy. Asian Pac J Cancer Prev. 15:1085–1091. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dong CG, Wu WK, Feng SY, Wang XJ, Shao JF
and Qiao J: Co-inhibition of microRNA-10b and microRNA-21 exerts
synergistic inhibition on the proliferation and invasion of human
glioma cells. Int J Oncol. 41:1005–1012. 2012.PubMed/NCBI
|
|
50
|
Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L
and Huang Y: miR-21 promotes migration and invasion by the
miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
Oncol Rep. 27:1660–1668. 2012.PubMed/NCBI
|
|
51
|
Jiang Y, Zhang SH, Han GQ and Qin CY:
Interaction of Pdcd4 with eIF4E inhibits the metastatic potential
of hepatocellular carcinoma. Biomed Pharmacother. 64:424–429. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Khosravi S, Tam KJ, Ardekani GS, Martinka
M, McElwee KJ and Ong CJ: eIF4E is an adverse prognostic marker of
melanoma patient survival by increasing melanoma cell invasion. J
Invest Dermatol. 135:1358–1367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PLoS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Que R, Ding G, Chen J and Cao L: Analysis
of serum exosomal microRNAs and clinicopathologic features of
patients with pancreatic adenocarcinoma. World J Surg Oncol.
11:2192013. View Article : Google Scholar : PubMed/NCBI
|
